Home Therapy Gastrointestinal infections
Home Therapy Gastrointestinal infections

gastroenteritis - Cryptosporidium species

Advices

≥ 18 years

Indications: Immuuncompetent
Priority Medication Remarks
Priority:
 1st choice 		Medication:

Remarks:

niet behandelen, tenzij langdurige darmklachten
Priority:
 2nd choice 		Medication:

Remarks:

nitazoxanide po, 500 mg, 2 dd, 3 dagen

General comments

In principe niet behandelen bij immuuncompetente personen.

Infectie is zelflimiterend in immuuncompetente patiënten. Bij persisterende diarree kan behandeling met nitazoxanide overwogen worden.

Beste therapie bij infecties in immuungecompromitteerden is het herstellen van de eigen afweer. Iedere antibiotische therapie is omstreden omdat effectiviteit in immuungecompromitteerden zeer beperkt is. Voor behandeling van immuungecompromitteerde patienten zie https://erasmusmc.adult.nl.antibiotica.app/nl/node/376971

Sources

  1. Pubmed.gov publication # 19632225

    Rossignol JF (2010) Cryptosporidium and Giardia: treatment options and prospects for new drugs. Exp Parasitol. 124:45-53.

  2. Pubmed.gov publication # 20689422

    Cabada MM, White AC Jr. (2010) Treatment of cryptosporidiosis: do we know what we think we know? Curr Opin Infect Dis. 23(5):494-9.

  3. Pubmed.gov publication # 19400754

    Pantenburg B, Cabada MM, White AC jr. (2009) Treatment of cryptosporidiosis. Expert Rev Anti Infect Ther 7: 385-91

  4. Pubmed.gov publication # 25278220

    Checkley W, White AC Jr, Jaganath D, et al.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect Dis. 2015;15(1):85-94.

  5. https://www.uab.edu/medicine/gorgas/images/docs/syllabus/2015/03_Parasites/RxParasitesMedicalLetter2013.pdf

    Drugs for Parasitic Infections. Treatment Guidelines from the Medical Letter. Vol 11 (Suppl), 2013.

Menu position
Metadata

Swab vid: G-146264.11
Updated: 03/12/2024 - 16:20
Status: Published